Global Health Equity

The International Gynecologic Cancer Society stands at the forefront in the global fight against gynecologic cancers, supporting and sponsoring programs “to enhance the care of women with gynecologic cancer worldwide through education and training and public awareness.”

Consistent with this mission and the current heightened global awareness of, and attention to, social and health inequity, IGCS is issuing this statement outlining its position on these important matters. Most succinctly put, IGCS supports all who espouse social and health equity around the globe.

Our statement provides clear context and specificity to our longstanding and forward-moving embrace of these important social justice and human right imperatives. We hope that it stimulates dialogue/discourse, and we welcome your comments. Most importantly, we hope that it prompts programming and actions that improve the lives of girls, women, and communities worldwide.

We would like to thank the working group for drafting the statement:

  • Dr. Andreas Obermair (Australia)
  • Dr. Marie Plante (Canada)
  • Dr. Michael Quinn (Australia)
  • Dr. Ritu Salani (USA)
  • Ms. Mary (Dicey) Jackson Scroggins (USA)

To continue the discourse, add to the literature, and prompt discussion and most importantly action, IGCS is currently drafting an article focused on global health disparities. The article will:

  • elucidate IGCS’ position more completely
  • site and explore specific systemic patterns and institutions that support or perpetuate inequities
  • highlight areas of women’s well-being that go beyond gynecologic cancer but are integral to their health and that of their communities
  • offer an action plan for moving forward.

In the coming weeks, we will review IGCS operations and programming for areas of potential improvement relative to issues of global health equity. Where appropriate and needed, we will enhance or restructure these areas such that they more explicitly align with our core belief that global health equity is a social justice and human rights imperative—one that we fully support.

After these initial assessments, we will regularly monitor programming and new program development for consistency with our core values summarized in the statement and with the attainment of documentable enhanced global health equity. Of course, we will keep members informed of this ongoing effort, programming adjustments, and progress in this important work. And, we will need and request your help in this organization-wide commitment to global health equity.


Global Health Equity: A Social Justice and Human Rights Imperative

IGCS Supports All Who Espouse Social and Health Equity Around the Globe 

As a core principle, the concept of global health equity—the absence of systematic disparities in health to allow the opportunity for every person to attain her (or his) full health potential—is embedded in the mission of the International Gynecologic Cancer Society (IGCS) and is reflected in the breadth of our membership and the design and implementation of our programs.

With over 3,100 members from low-, middle-, and high-income countries around the globe, IGCS has purposefully developed an inclusive membership framework that encourages interaction and growth across diverse social, political, and health care systems. Through this framework, IGCS connects our members with specific needs to those with corresponding resources and programs; forms partnerships; educates, trains, and mentors clinicians, survivors-patients, and caregivers; and otherwise enhances benefits to women not only in optimal but also in the most challenging circumstances and environments.

Since our establishment in 1987 as a forum for the worldwide exchange of scientific information, IGCS has grown as a model for global health equity, and consistent with that history and our current operation, IGCS supports individuals and organizations meaningfully engaged, at whatever level, in the journey toward social and health equity worldwide.

As we lead the global fight against gynecologic cancers, we do so with the clear understanding that prompting, promoting, and inspiring maximum achievable health outcomes for every girl and woman (and thus every community)—wherever and under whatever circumstance she might live—are fundamental to the social justice and human rights imperative of global health equity, irrespective of

  • national origin or political system
  • location of residence/citizenship
  • race or ethnicity
  • religion
  • sexual orientation and/or gender identity
  • local, national, or regional leadership
  • sociodemographic factors
  • geopolitics
  • any other intervening factor

In keeping with this understanding and by focusing our work and service where they can have the greatest impact on health and well-being, IGCS supports the empowerment of girls and women—and the health professionals who serve them—so they can attain the best health and life outcomes specific to but not limited to gynecologic cancers.

In the coming weeks and months, IGCS will review our programming. Furthermore, as an act of social responsibility, we will continually review the health equity-explicit initiatives within our portfolio and identify the need for new initiatives where none exist. After all, our mission “to enhance the care of women with gynecologic cancer worldwide through education and training and public awareness” and our demonstrated commitment to global health equity explicitly require as much.

Download PDF of this statement.

Season’s Greetings from IGCS

Dear IGCS Members and Friends,

This year has been like no other in our lifetime. My thoughts and prayers are with everyone who has been affected by the coronavirus and I would like to express my gratitude to those of you who are frontline workers and caregivers who have selflessly provided care to the most vulnerable in impossible circumstances. You give your strength to so many. I would also like to recognize and applaud the scientists and researchers within our community who dedicate their careers to scientific innovation and the development of life-saving technologies and therapies. Your work is so important.

I think this year it has been more apparent than ever that we are all connected regardless of our beliefs, culture, or geography. I am heartened by what I have seen this year – the global collaboration, support, and communication that has continued despite our inability to gather in the same rooms. The challenges of this year jumpstarted our virtual programs which allowed us to reach thousands of healthcare professionals, advocates, patient-survivors, and collaborate with organizational partners from all over the world. Many of you are new to the IGCS community – I am so glad you are here.

Thank you for participating in our virtual events whether it be our Surgical Film Festivals, Virtual Tumor Boards, Global Patient Perspectives Roundtables, and of course the 2020 Annual Global Meeting and the Survivor-Caregiver Public Summit. Through it all, I have seen how you have been supportive of one another. What a comfort it has been to know that we were never alone; that others were facing similar challenges and that we could find solutions to shared problems together. Thank you for your dedication, collaboration, and courage.

As 2020 comes to an end and knowing that this holiday season may not be as festive as previous years, I wish you moments of peace amid difficult situations, connections with family and friends even if you cannot touch, and the comfort of warm memories of holidays past. We are seeing glimmers of promise that the pandemic will wane, so let’s welcome 2021 with hope.
Thank you for being a part of our community. I wish you all a safe and joyful holiday season and may the New Year bring you good health and happiness.




Mary C. Eiken, MS


Congratulations to IGCS Global Curriculum Graduates!

Congratulations to three fellows from Maputo Central Hospital in Mozambique completing the IGCS Gynecologic Oncology Global Curriculum & Mentorship Program!

Veja esta mensagem em Portugues.

Dr. Dércia Changule
Maputo Central Hospital, Mozambique
Dr. Siro Daud
Maputo Central Hospital, Mozambique
Dr. Ricardina Rangeiro
Maputo Central Hospital, Mozambique

The Global Curriculum was established in 2017 under the leadership of then-President, Michael Quinn. It is a comprehensive two-year education and training program designed for regions around the world that do not currently have formal training in gynecologic oncology.

Congratulations to Drs. Changule, Daud, and Rangeiro on achieving this important milestone. They will be the first formally trained gynecologic oncologists in Mozambique.

To learn more about the program, please download the 2019 Annual Report.

Those who would like to learn more about how to contribute to the mentorship and training aspects of this program, please email

Dr. Dércia Changule
Maputo Central Hospital, Mozambique
Fellowship Training Completed: 2020

“Thank you very much to the whole IGCS team. I am aware that with the program many Mozambican women will be benefited, (during the training, many Mozambican women with gynecological cancer received the appropriate treatment), it is our duty to continue treat them properly.

Special thanks to Drs.: Kathleen Schmeler, Ellen Baker, Mila Pontremoli Salcedo, Geórgia Fontes Cintra, Renato Moretti, Andre Lopes and Marcelo Vieira who were engaged to train us (I am sure that we can always count with you), you trained us with professionalism and goodwill, in a country that did not even have an oncologist gynaecologist. Thank you, amazing team!”

Dr. Siro Daud
Maputo Central Hospital, Mozambique
Fellowship Training Completed: 2020

“The IGCS GC Program changed the approach of diagnosis and treatment of gynecologic malignancies in Mozambique. Our training played a key role in this change. I am happy to be part of this program.”

Dr. Ricardina Rangeiro
Maputo Central Hospital, Mozambique
Fellowship Training Completed: 2020

“It was a great and unique opportunity to be part of this program. I will be forever grateful to the mentors and all the staff involved …Mozambique is now part of Gynecology Oncology team!!!”

We would like to sincerely thank their local mentors in Mozambique: Drs. Elvira Luis and Magda Ribeiro as well as our six volunteer international mentors: Drs. André Lopes (Instituto Brasileiro de Controle do Câncer e Instituto do Câncer do Estado de São Paulo), Georgia Fontes-Cintra (Hospital Sírio-Libanes), Kathleen Schmeler (The University of Texas MD Anderson Cancer Center), Marcelo Vieira (Hospital Israelita Albert Einstein), Mila Pontremoli Salcedo (Santa Casa de Misericórdia de Porto Alegre/Universidade Federal de Ciências da Saúde de Porto Alegre/ The University of Texas MD Anderson Cancer Center) e Renato Moretti (Hospital Israelita Albert Einstein).

2021 Membership Renewal

It’s that time of year! If your membership is set to expire on December 31st, please make sure to renew so that we may continue to serve you in 2021.

On behalf of the IGCS leadership, I want to thank all of you in advance for paying your 2021 membership dues. We know you have other organizations that you belong to and IGCS is very grateful for your willingness to continue your membership with us. Dues allow organizations, like IGCS, to fund important programs that are essential to you, our members, and for you to take advantage of the many member benefits offered.

IGCS, being a member driven organization, relies on the members to support us in many ways – including renewing your membership.

Please sign in to your member account and submit your membership dues for 2021 or pay in advance up to three years. If you have questions or need assistance, please contact the IGCS Membership Manager, Cathy Fearing at

As always, we thank you for your continued dedication. We look forward to serving you for another year!

Mary Eiken, MS

2020 Award Recipients

These award recipients will be recognized at the upcoming xDigital Annual Global Meeting of the International Gynecologic Cancer Society which will be held in a fully digital setting this September 10-13, 2020. The Awards Ceremony will take place during the Opening Ceremony on September 10th at 2:00 p.m. UCT.

Please join us in congratulating them on their achievements!

2020 Lifetime Achievement Award Recipients

Monica Bacon, RN

Co-Founder of the Gynecologic Cancer InterGroup (GCIG), Ms. Bacon is a recipient of the IGCS 2020 Lifetime Achievement Award for her lifelong dedication to women’s health and serving the gynecologic cancer community though nursing, clinical trial coordination and international team building, advocacy, and volunteerism.

Read more about Monica.

Nicoletta Colombo, MD, PhD

Principle investigator of several international clinical trials and established author, Professor Colombo is the recipient of the IGCS 2020 Lifetime Achievement Award for her exemplary leadership in multiple gynecologic oncology organizations, and lifelong commitment to science, research and clinical trials.

Read more about Nicoletta.

2020 Excellence in Teaching Award Recipient

Rahel Ghebre, MD, MPH

For her mentorship and leadership with gynecologic oncology sub-specialty training programs in Ethiopia, specifically at Addis Ababa University and initiating a program at St. Paul’s Millenium Medical College. This award recognizes a deep commitment and dedication to gynecologic oncology, exemplifying the core components of teaching and education.

Read more about Rahel.

2020 Distinguished Advocacy Award Recipients

Runcie C.W. Chidebe & Project PINK BLUE
For outstanding advocacy throughout Nigeria and in global forums, including founding Project PINK BLUE—an organization focused on cancer advocacy, oncology training, and research—as well as influencing the establishment of the National Institute for Cancer Research and Treatment, developing numerous programs to serve the most needy, and changing cancer awareness and care throughout Nigeria

Read more about Runcie & Project PINK BLUE.

Nathalie Dauphin McKenzie, MD (USA) &
Innovating Health International (Haiti)
For courageous, ongoing advocacy for survivors-patients in the USA and Haiti, including traveling to Haiti several times a year—at great personal risk—to perform life-saving surgeries (otherwise unavailable) and to train oncologists to do the same, currently primarily through Innovating Health International, a Port-au-Prince based women’s cancer center, where no patient is ever turned away because of treatment costs

Read more about Nathalie & Innovating Health International.

Ovarian Cancer Research Alliance
For dedicated service to advocate and research communities, as the largest global, non-government funder of ovarian cancer research, having raised over $100 million for research/services and developed and conducted extensive advocacy programs including Survivors Teaching Students® through which ovarian cancer survivors and family members have trained/reached nearly 100,000 medical and other health professions students

Read more about the Ovarian Cancer Research Alliance.

2020 IJGC Award Recipients

The International Journal of Gynecological Cancer (IJGC) is a joint publication of the International Gynecologic Cancer Society (IGCS) and the European Society of Gynaecological Cancer (ESGO). The IJGC Awards are presented at the IGCS and ESGO Annual Meetings on alternate years. This year, the IJGC Awards will be presented at the 2020 IGCS Annual Global Meeting.

Most Downloaded Paper Award (2020)

Gloria Salvo, MD
for the paper titled
“Updates and management algorithm for neuroendocrine tumors of the uterine cervix”

Editor’s Choice Award (2020)

David Cibula, MD, PhD
for the paper titled
“European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer”

View Top 10 Journal Reviewers of 2020

CEO Update: COVID-19 Survey Results

Dear Members and Friends,

In this CEO Update, I’d like to share with you the results from our recent COVID-19 survey, provide an update on IGCS 2020 abstracts and our upcoming Surgical Film Festival with AAGL, and remind readers of the International Journal of Gynecological Cancer to complete the 2020 readership survey.

COVID-19 Survey Results

We would like to thank our members for taking the time to complete our international survey of gynecologic cancer care providers to help us better understand the global impact of the COVID-19 pandemic on cancer care in the initial months of the pandemic. An executive summary of the results is now available.

Download COVID-19 Survey Results Executive Summary

We received responses from a total of 270 participants from 62 countries, with representation largely from North America, South America, and Asia. 83% were gynecologic oncologists and the rest included medical oncologists, radiation oncologists, pathologists, and nurses. The primary practice of 97% of participants is in clinical work and 91% work in an urban setting. 70% work in academic medical centers while 26% work in community hospitals.

From the survey responses, we learned that there is a definite and urgent need for the IGCS to comprehensively evaluate and understand the impact of the COVID-19 pandemic on gynecologic cancer practice and women’s cancer care. This understanding goes to the raison d’être of the Society in supporting its membership through education, advocacy, and political activism for women living with cancer all over the world. If you are interested in informational resources IGCS has compiled related to cancer care and COVID-19, please visit our COVID-19 page for resources, articles and recordings of educational tumor boards.

I would also like to thank Dr. Joseph Ng, IGCS Council Member and Chair of the Mentorship and Training Committee for his work in developing the survey questions and Dr. Li Min Lim for analyzing and compiling the executive summary.

The IGCS will be diving deeper and into some of the comments and responses you have provided. We intend to share what we find on these deep dives across our entire suite of information-distribution platforms including social media and in our society journal, the International Journal of Gynecological Cancer.

IGCS 2020 xDigital Annual Global Meeting

Abstract and Surgical Film Submission for the IGCS 2020 Annual Global Meeting closed on July 15, 2020 at 11:59 pm PDT. We are grateful to have received over 500 abstracts and surgical films.

Late Breaking Abstracts will be accepted from July 25-August 15. Please note that the late breaking submission site is reserved for high priority data that was not fully available at the time of original submission deadline on July 15. Other submissions will not be considered for acceptance.

There is still plenty of time to register for IGCS 2020. Learn more about the meeting which will be 100% digital. Session details will be released soon but until then, please view the program overview to see all the great sessions that will be offered.

IGCS/AAGL Surgical Film Festival

The next IGCS/AAGL Film Festival covering surgical complications will be held July 29, 2020 at 5:00 pm CDT. This online event is free but registration is required. View the program outline and speakers.


IJGC Readership Survey (July 2020)

The International Journal of Gynecological Cancer is conducting a readership survey to collect feedback from IGCS members and subscribers regarding journal content and educational offerings such as podcasts, video articles and different article types.

Please complete the IJGC survey here.


In closing, I’d like to thank the numerous volunteer leaders who allow IGCS to achieve our goals and better the care for women with gynecologic malignancies.


Mary Eiken, MS

Welcome, SASGO!

We are so pleased to announce that the South African Society of Gynaecologic Oncology (SASGO) has joined the IGCS Strategic Alliance Partnership.

SASGO Members will now benefit from dual membership and gain access to IGCS Member benefits such as the Early Career Research & Publications Network,  the online member Education Portal (including the new Pathology Corner), AAGL’s SurgeryU video library, discounted registration for the IGCS Annual Global Meeting, and access to our online member community Social Link.

Greta Dreyer, who serves as SASGO President and as an IGCS Council Member, was instrumental in communicating with SASGO Council and Members and sharing feedback with IGCS leadership to discuss challenges and opportunities to collaborate and share resources to improve treatment of women affected by gynecologic cancers in South Africa.

SASGO was founded in 2006 to promote excellence in gynaecologic cancer care through training, research, and quality of care. They also advocate on behalf of women in South Africa by liaising with concerned governmental and non-governmental groupings, institutes for training and examination, authorities, and related advisory and research groups.

South Africa, with a population of 55 million, is a multiethnic society encompassing a wide variety of cultures and religions with 11 official languages. According to the International Agency for Research on Cancer, breast and cervical cancer are the most prevalent cancers affecting women in South Africa with cervical cancer being number one cause of cancer-related deaths. Vulvar, uterine, and ovarian cancer are also among the top eight most prevalent cancers in the country.

We look forward to our partnership with SASGO, to serve the gynecologic cancer professionals in the region, unite them with our global community, and to find ways to achieve our common goals to fight gynecologic cancers through training, education and public awareness.

IGCS Updates April 2020

IGCS Members,

We trust this finds you all well and safe during a very unprecedented time. We think of all of you, your families, and colleagues often. We hope that the following is informative, and you can see what’s new from the IGCS.

Cast your Vote: 2020 Council Election

Online voting for the 2020 Council Election is open through May 5th. All voting members should have received an email from with a link to the ballot on April 5th and those who have not voted will receive weekly email reminders. Members may also visit and login with their IGCS username and password to access the ballot.

Read more about the open positions and excellent group of candidates here.

COVID-19 Virtual Tumor Boards & Resources

COVID-19 has transformed the world in just a few short months. IGCS Members all around the world are adapting to the changes in many aspects of life including clinical decision-making for gynecologic cancer patients. Many members are discussing their experiences and sharing resources in the online IGCS Member community, Social Link. Log in and join the discussion!

We are hosting a series of virtual tumor boards for IGCS Members with a special focus on the impact of COVID-19 in the management of gynecologic cancer patients. The first tumor board was held on April 4th, with over 275 attendees from all around the world heard from experts who discussed delays in diagnostic and therapeutic interventions. A recording of the tumor board, the slides, and information about future tumor boards can be viewed here.

Keep an eye on your inbox to learn about and register for our future virtual tumor boards on COVID-19 and gynecologic oncology taking place April 18th and 25th. You can also view the list of resources, regional guidelines, and news we’ve compiled here.

Education Highlight

A new IGCS-IJGC Interactive Learning Article is available in the Education Portal: Decision analysis for secondline maintenance treatment of platinum sensitive recurrent ovarian cancer: a review. Interactive Learning Articles are developed with select articles published in the International Journal of Gynecological Cancer. A quiz format enhances the learning experience, allowing readers to test their knowledge on the material presented in the article.

The March compilation of In-the-Know (Ed’s List) is also available to download in the Literature Library.

IGCS Articles Published in IJGC

We recently developed and published two articles in the International Journal of Gynecological Cancer.

The first article in February was the European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.

Just recently at the end of March, the IGCS Intraoperative Technology Taskforce published Update on Near Infrared Imaging Technology: Beyond White Light and the Naked Eye. Indocyanine Green and Near Infrared Technology in the Treatment of Gynecologic Cancers.

Lead author, Dr. Nadeem Abu-Rustum says “near infrared imaging has the potential to revolutionize our intraoperative management for lymphatic mapping and micro perfusion assessment. The technology is available in many cancer centers worldwide and will likely play an increasing role in gynecologic cancer surgery for lymphatic mapping of uterine and vulva cancer as well as skin and bowel perfusion assessment.”

IGCS Annual Global Meeting: Rome 2020

Our thoughts and concerns have been with all of Italy and the entire globe since the onset of COVID-19. We continue to monitor the situation very closely as it pertains to our plans to hold IGCS 2020 in Rome this September. Our President, Dr. Roberto Angioli recorded this message a few weeks ago and we are happy to see that the situation in Italy is improving day by day.

Our program chairs, staff, and conference organizers have been working diligently to ensure that we provide a fantastic educational program for our members and the global gynecologic oncology community, both in person and digitally. We are very excited to share this digital environment in the coming weeks and will send you a demonstration to showcase the interactive ability of a fully digitized meeting for participants who are are unable to travel to Rome. We will also be sharing our new deadlines for abstracts and registration.

Membership & Social Link

We’d like to thank all of you for renewing your membership for 2020 and welcome to those who are new to the society! We hope you are all taking advantage of your membership – the benefits list is now available in English, Chinese, Spanish, and Russian. It’s easier than ever to communicate with your fellow IGCS Members through the online community, Social Link.

Search the online membership directory and browse the discussion forums to connect with other members today.

Follow us on Social Media

Do you follow us on Facebook, Twitter, LinkedIn or Instagram? If you don’t, you may be missing out! Over the last several months, we’ve been working to increase our presence on social media to keep you all informed of everything that we are doing.

As you can see, 2020 is proving to be a busy year for IGCS! Make sure to follow us on social media and visit frequently to check our featured announcement section so you can stay in the know.

Stay safe and be well.

Prof. Roberto Angioli
IGCS President
Ms. Mary Eiken




Nominations for Distinguished Advocacy Award

The Award

The Annual IGCS Distinguished Advocacy Award recognizes advocates and/or advocacy organizations that provide active, dedicated service to patients-survivors, families, caregivers, and communities—at a local, regional, or international level. The Award, reserved for those most persistently engaged in the fight against gynecologic and other cancers,

  • recognizes those currently engaged in activities and projects that tangibly provide benefit to patient-survivor communities
  • highlights best practices and outstanding individuals and organizations in various settings throughout the world
  • inspires others to engage so generously

Annually, IGCS honors up to three individuals and organizations from different regions of the world, and special consideration is given to those who collaborate beyond their community or country of residence. Award recipients will

  • attend the 2020 IGCS Annual Global Meeting in Rome (September 10-12), with support from IGCS
  • be recognized at the Global Meeting during a Plenary session and during the Survivor-Caregiver Symposium
  • receive a plaque in recognition of the Award
  • be highlighted on the Advocacy pages of the IGCS website

Accepting Nominations for 2020

IGCS is currently accepting nominations for its 2020 Distinguished Advocacy Award. The deadline for receipt of nominations for the 2020 Award is April 15, 2020, at 11:59 pm EST. Award recipients will be determined by a Selection Committee with IGCS Council consultation. In selecting award recipients, we will consider global distribution of the award and regional ableness; however, these will not be the primary considerations. We accept self-nominations.

Award recipients must be patients-survivors, family members, caregivers, or other individuals who make outstanding contribution(s) to the patient-survivor community and be engaged in one or more of the following areas:

  • advocating for enhanced cancer awareness and prevention
  • providing or advocating for the delivery of the highest-quality cancer care
  • supporting achievement of the highest quality of life possible (to include support or palliative care)
  • implementing program(s) that support and/or advance health equity
  • collaborating with other advocates and/or advocacy organizations to benefit patients-survivors across geographic boundaries and demographics

Nominees do not have to belong to an established organization but must be active in their own community and/or beyond. In each calendar year, only one person or organization from a region can receive the Award.

Click here to Download the Nomination Form.
Click here to Submit the Completed Nomination Form.

If you have questions or need assistance, please email the IGCS Director of Global Outreach and Engagement, Mary (Dicey) Jackson Scroggins at

IGCS & WOCC Join Forces


Announcing a Strategic Advocacy Partnership Between the International Gynecologic Cancer Society and the World Ovarian Cancer Coalition

It is my pleasure to announce a Strategic Advocacy Partnership between the International Gynecologic Cancer Society (IGCS) and the World Ovarian Cancer Coalition (WOCC). This partnership maximizes the collective influence, membership, force, and reach of these two premiere organizations and establishes a framework through which they will provide tangible benefit to gynecologic cancer survivors-patients worldwide, with special emphasis on ovarian cancer.

Established in 2016, WOCC is a not-for-profit organization with 145 patient advocacy organization partners in 37 countries. WOCC works to ensure that every woman diagnosed with ovarian cancer has the best chance of survival and the best quality of life possible, wherever she may live. Its mission aligns perfectly with that of the IGCS of enhancing the care of women with gynecologic cancer worldwide. Uniting the globe in the fight against gynecologic cancers since 1985, IGCS currently has over 3,200 members in 115 countries. The membership of both organizations encompasses low-, middle-, and high-resource countries, consistent with their commitment to global health equity.

Elisabeth Baugh, Chair of the World Ovarian Cancer Coalition, explains, “As the largest global ovarian cancer patient advocacy network, the World Ovarian Cancer Coalition is committed to making a difference to the lives of all women affected by ovarian cancer. This strategic partnership creates a powerful global advocacy movement, uniting and strengthening patient and clinical voices to act as a force for urgent change. It is our firm belief that we will achieve much more together.”

With each organization retaining its independence, focus, and governance and with each committed to mobilizing outstanding global leadership, experts, and advocacy to reduce the burden of gynecologic cancers globally, this partnership does indeed represent a formidable force for change.

Emphasizing the importance of advocacy partnerships, IGCS President Roberto Angioli notes, “This partnership with the World Ovarian Cancer Coalition is representative of our commitment to working collaboratively with advocates worldwide to ensure best outcomes for all women and families affected by gynecologic cancers. We will continue to partner with local, regional, and global advocacy groups across all gynecologic cancer sites. These partnerships are essential to our mission.”

And, specifically, in activating this partnership, we will

  • Launch the WOCC’s Global Ovarian Cancer Charter—a call-to-action to all involved in the care of ovarian cancer survivors-patients—during the 2020 IGCS Annual Global Meeting.
  • Convene cancer site-specific partnership meetings and other forums that support the IGCS-initiated Global Advocacy Network focused on gynecologic cancers.
  • Integrate into IGCS, WOCC, and other international meetings, our individual organization-specific, mission-driven programming that supports advocacy broadly.

Together, IGCS and WOCC will amplify the global voices of gynecologic cancer survivors-patients and will prompt and accelerate change that expands awareness and options, improving survival rates and survivorship. To manage joint initiatives, each organization has a dedicated partnership lead—Dicey Jackson Scroggins, IGCS Director of Global Outreach & Engagement, and Clara MacKay, WOCC Executive Director.

We are well positioned to take on the challenges and excited by the opportunities to benefit women and families—wherever and under whatever circumstance they might live.


Mary Eiken, MS
IGCS Chief-Executive Officer